Evidence map›Paper›PMID 33136016›Full record

ArticleThe journal of international advanced otology2020

Validity and Test-Retest Reliability of the translated Stapesplasty Outcome Test 25 for Measurement of Disease-Specific Quality of Life in Patients with Otosclerosis.

Mascha Hildebrandt, Kasper Daugaard Larsen, Henrik Glad, Bjarki Djurhuus

Open access · diamondAbstract read
In one paragraph

Article in The journal of international advanced otology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Translation, cultural adaptation and validation of the Stapesplasty Outcome Test 25 (SPOT-25) for measurement of disease-specific health-related quality of life in Dutch otosclerosis patients: a prospective study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mascha HildebrandtDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Kasper Daugaard LarsenDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Henrik GladDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Bjarki DjurhuusDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Zealand University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the validity and test-retest reliability of the Danish Stapesplasty Outcome Test 25 (SPOT-25) version. MATERIALS AND

methodsThe German SPOT-25 questionnaire-consisting of 25 questions within the subscores "hearing function," "tinnitus," "mental condition," "social restrictions," and "general quality of life," found to be significant in terms of health-related quality of life in patients with otosclerosis-was translated into Danish in a three-step process according to the guidelines provided by the International Collegium of Rehabilitative Audiology. In total, 35 patients with otosclerosis were included as cases and 35 individuals without ear-problems as controls. The SPOT-25 questionnaire was filled out once by the patients and twice by the controls. Pure tone average (0.5, 1, 2, and 3 kHz) (PTA4) was obtained for cases.

resultsThe SPOT-25 clearly discriminated the individuals with otosclerosis from con-trols within all subscores (p<0.001). The internal consistency within the subscores was good to excellent with Cronbach alpha values of 0.85-0.95. The reproducibility (estimated by the control group) was moderate to high, with an intraclass correlation of 0.58-0.94 within the subscores. Although the SPOT-25 subscores within "hearing" and "social restrictions" showed a moderate correlation with PTA4 (Pearson correlation coefficient 0.51 and 0.42, respectively), this was not the case for the subscores regarding "tinnitus," "mental condition," and the "general."

conclusionThe SPOT-25 questionnaire can be used as a valuable complement to audiometric data in patients with otosclerosis, especially for estimating factors such as tinnitus and "mental condition," which do not correlate with the audiometric data.

Indexed as

OtosclerosisTinnitusHumansQuality of LifeReproducibility of ResultsSurveys and Questionnaires

Identifiers

PMID33136016
PMCPMC7901448
OpenAlexW3093787447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.